Vyne Therapeutics

Late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus. Learn more

Launch date

2011

Employees

Market cap

Enterprise valuation

(AUD80m) (Public information from Sep 2024)

Menlo Park California (HQ)

https://vynetherapeutics.com

https://twitter.com/vynetx https://www.linkedin.com/company/menlo-therapeutics-inc

Authorizing premium user...